Construction of PEG-PAMAM dendrimer-based TAG۷۲-targeting nanocarrier for t-Bid gene delivery to colorectal tumor cells
- سال انتشار: 1390
- محل انتشار: مجله تحقیقات پاتوبیولوژی، دوره: 14، شماره: 2
- کد COI اختصاصی: JR_PRJMS-14-2_006
- زبان مقاله: انگلیسی
- تعداد مشاهده: 139
نویسندگان
M.Sc. Student, Department of Medical Biotechnology, Faculty of Medical Science, Tarbiat Modares University, Iran
Assistant Professor, Department of Medical Biotechnology, Faculty of Medical Science, Tarbiat Modares University, Iran
Assistant Professor, Cancer Research Center, Institute of Cancer, Tehran University of Medical Sciences, Iran
Ph.D. Student, National cell bank of Iran, Pasteur Institute, Iran
چکیده
Objective: The objective of this study is to develop and assess targeted PAMAM-PEG nanocarrier with anti-TAG۷۲ nanobody for t-Bid gene coding construct delivery into the human colonic adenocarcinoma cells. Materials and Methods: Nanobody (Nb) coding sequence was subcloned into pSJ expression vector for large-scale production and then Nb was purified by Ni++ affinity chromatography. SDS-PAGE and western blot analysis were performed to verify purifiction. PAMAM was reacted with PEG at the ratio ۱:۲ (mol/mol) and anti-TAG۷۲ Nb at the ratio ۱:۱ (mol/mol). Surface charge and size of resulting nanoparticles were evaluated by Malvern zeta sizer and Nanosight. Efficiency of constructed gene carrier for t-Bid, a killer gene, delivery into colonic adenocarcinoma cells in in vitro was assessed using real time PCR and cell counting assays. Results: Production of nanoparticles with the average size of ۱۶۲±۹۲ nm and +۴.۵۷±۰.۵۲ zeta potential was confirmed by nanosight and Malvern zeta sizer in order. Gel retardation assay result verified efficiency of carrier for pDNA comlexation. Real time PCR results confirmed the target gene overexpression in the cancerous cell lines. Conclusion: The results of this research confirms the efficiency of PAMAM dendrimers for gene transferring, positive effect of PEGylation and targeting of nanoparticles by anti-TAG۷۲ nanobody.کلیدواژه ها
Anti-TAG۷۲ Nanobody, Targeted Gene Therapy, Human Colonic Adenocarcinoma, PAMAM-PEG Nanocarrier, نانوبادی علیه TAG۷۲, ژن درمانی هدفمند, آدنوکارسینومای کولون انسانی, نانوحامل پلی آمیدوآمین-پلی اتیلن گلیکولاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.